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n Abstract Autoreactive antibodies are etiologic agents in a number of autoim-
mune diseases. Like all other antibodies these antibodies are produced in developing B
cells by V(D)J recombination in the bone marrow. Three mechanisms regulate autore-
active B cells: deletion, receptor editing, and anergy. Here we review the prevalence
of autoantibodies in the initial antibody repertoire, their regulation by receptor editing,
and the role of the recombinase proteins (RAG1 and RAG2) in this process.
INTRODUCTION
Antigen receptor diversity is generated by random rearrangements between vari-
able (V) diversity (D) and joining (J) gene segments in developing B cells and
T cells (1). This receptor diversity ensures efficient immune responses to a uni-
verse of rapidly evolving potential pathogens. However, random gene reassortment
can also produce self-reactive antibodies that could cause “horror autotoxicus,”
as pointed out by Ehrlich (2). Burnett, Talmage, and Lederberg provided a frame-
work for understanding how self-reactive lymphocytes might be removed from
the nascent repertoire as part of the clonal selection theory (3–5): They proposed
that any self-reactive antibody producing lymphocytes would be deleted during
development. In the past 20 years transgenic experiments in mice have shown that
at least three mechanisms account for silencing of self-reactive antibodies during
B cell development in the bone marrow: receptor editing, deletion, and anergy
(6–9). One of these mechanisms, receptor editing, relies on V(D)J recombination
to obviate autoantibody production in vivo. Here we review recent work on as-
pects of V(D)J recombination relevant to production and regulation of autoreactive
antibodies in vivo.
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MOST NASCENT B CELLS PRODUCE AUTOANTIBODIES
How B cells produce a diverse antibody repertoire while maintaining self-tolerance
has been an important question since the time of Ehrlich (2). Landsteiner’s finding
that the antibody repertoire is almost infinitely diverse further stressed the potential
importance of avoiding self-reactivity and raised the problem of prevalence of
autoantibodies in the initial repertoire (10).
A number of investigators found that the majority of nascent immature B cells
are deleted before they reach the mature B cell compartment, suggesting that
autoreactive B cells might be a large part of the initial repertoire (11–15). Only
10%–20% of the bone marrow immature cells reach the periphery, and as few as
3% contribute to the mature B cell pool (14, 16–18). Furthermore, deletion was
not random because there was a specific shift in the representation of antibodies
in the repertoire between the immature and mature B cell stages (19–21).
The number of self-reactive antibodies was determined for human B cells by
single cell analysis of the bone marrow and blood (22) (Figure 1). Two types of
autoreactive antibodies were measured by ELISA, antinuclear antibodies (ANAs)
and antibodies to defined antigens such as DNA, insulin and LPS. Antibodies that
bound to more than one of these defined antigens were considered polyreactive.
The ANAs were assayed by ELISA on HEp-2 cell lysates and verified by indi-
rect immunofluorescence. Fifty-five percent to 75% of all antibodies in the early
immature B cell compartment (B cells with the surface phenotype of pre-B cells
that contained in-frame Ig• or Ig‚ chains) produced self-reactive antibodies (22).
The self-reactive antibodies were lost from the B cell repertoire at two discrete
checkpoints in development. The first checkpoint was between the early immature
B cell stage and the immature B cell stage. Nearly all antibodies (poly)reactive
with defined antigens were lost in this early transition in the bone marrow. ANA
antibodies were lost from the repertoire in the immature B cell compartment and
also in the periphery at the transition between the immature and mature B cell pool.
Therefore, the majority of nascent human B cells is self-reactive. Future experi-
mentation should focus on understanding changes in the efficiency of autoantibody
removal that might lead to increased susceptibility to autoimmunity.
RAG EXPRESSION AND ANTIBODY ASSEMBLY
IN DEVELOPING B CELLS
RAG1 and RAG2 proteins catalyze V(D)J recombination and antibody gene as-
sembly (23, 24). RAGs bind to and cleave DNA at conserved recombination signal
sequences (RS) that flank immunoglobulin (Ig) and T cell receptor (TCR) gene
segments (25). These proteins are essential for the recombination reaction, and
loss of either one in mice or humans results in complete block of lymphocyte
development (26–28).
RAG1 and RAG2 are only coexpressed in developing lymphocytes, and the
level of expression is regulated in a developmental stage–specific manner (29, 30)
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(see Figure 1). The first B cells to express RAG1 and RAG2 are early lymphoid
committed progenitors found in fraction A1 (31, 32). These cells are Lin¡CD27Cc-
kitHiScaHi and express low levels of RAGs and exhibit low levels of recombinase
activity as measured by recombination of antibody D and J gene segments (33).
RAGs are further induced in pro-B cells where Ig heavy chain gene assembly be-
gins (31, 32, 34). Successful heavy chain gene recombination leads to expression
of membrane Ig heavy chains („), which in turn induce clonal expansion, RAG
downregulation, heavy chain allelic exclusion, and progression to the pre-B cell
stage (35–40). It is essential for heavy chain allelic exclusion to be established at
this stage of B cell development because persistent recombination might inactivate
the productively rearranged heavy chain or produce a cell with two heavy chains
and multiple antibody specificities. RAG1 and RAG2 downregulation is likely an
important initial aspect of establishing allelic exclusion at the heavy chain lo-
cus. However, exclusion is maintained in later B cell stages by RAG-independent
changes in heavy chain accessibility that appear to be induced through IL-7 (41,
42). RAG1 and RAG2 expression is downregulated in cycling pre-B cells but it is not
known whether this downregulation is mediated at the transcriptional level or at the
level of mRNA stability (43). Decreased transcription is suggested by decreased
GFP expression in mice that carry YFP and GFP inserted into the RAG1 or RAG2
genes, respectively (32, 44). RAG protein levels are also regulated by phophory-
lation of the RAG protein, which decreases the half-life of the protein (45).
A second wave of RAG expression is induced when pre-B cells stop dividing,
and it is associated with onset of high levels of Ig light chain gene recombination
(35, 46). Upon successful expression of an Ig light chain gene and assembly of a
functional BCR, pre-B cells become immature B cells. Immature B cells are the
first B cells to express surface IgM, and it is in this compartment that antibodies
are initially tested for self-reactivity and that central B cell tolerance is established
by receptor editing or deletion (6, 7). Immature B cells display two features that
facilitate induction of central tolerance: persistent RAG expression that allows for
receptor editing, and apoptosis in response to high levels of BCR cross-linking
that promotes deletion (32, 44, 47, 48).
PERSISTENT RAG EXPRESSION AND RECEPTOR EDITING
Receptor editing involves replacement of self-reactive antibody V region (7, 49)
genes by V(D)J recombination (6). Gene replacement by persistent V(D)J recom-
bination was first described in B cell lines in vitro (50–52). In mice, it was noted
that Ig• transgenes did not induce high levels of allelic exclusion and that there was
frequent persistent V(D)J recombination with some antibody transgenes (53, 54).
However, the potential physiologic significance of secondary recombination of Ig
genes in maintaining tolerance was only appreciated from studies of transgenic
mice carrying anti–double stranded DNA or anti-MHC antibodies (6, 7). In these
mice, immature B cells are exposed to multivalent self-antigens at early stages
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of development (8, 55). Most of these B cells are deleted, but a small cohort of
B cells escapes deletion and migrates to the spleen and lymph nodes where they
accumulate with age (6). It was shown that while the transgenic heavy chain was
present in the B cells that escape deletion, they expressed an endogenous, non-
transgenic • or ‚ gene, and the resulting chimera was no longer self-reactive (6, 7,
49). Thus, the nontransgenic • or ‚ gene was said to “edit” the original transgenic
self-reactivity.
Further insight into light chain editing came from the analysis of the transgenic
mice that carry only the 3H9 heavy chain of an anti-DNA antibody (49, 56). 3H9
produces anti-DNA when combined with most light chains but a small group of
light chains with low isoelectric points such as V•12A block anti-DNA reactivity.
Despite the high level of reactivity of 3H9 with DNA, splenic B cells from these
mice did not produce anti-DNA antibodies. 3H9 peripheral B cells showed highly
skewed V• and J• usage with a large number of cells expressing V•12A, and the
majority of the V• genes were joined to J•5, indicating that multiple recombination
events had occurred on the same chromosome (49). Efficient light chain “editors”
differed from other • light chains in that their CDRs are very acidic and have the
capacity to prevent DNA binding by neutralizing the arginines in the CDR3 of
3H9 (57). Enhanced editing was associated with high levels of RAG expression,
suggesting that editing induced or prolonged RAG expression (7).
The efficiency of editing was assessed using mice produced by gene targeting
to express anti-MHC (H-2Kk-b) or anti-DNA heavy and light chains (58, 59). In
contrast to the severely reduced numbers of mature B cells reported in conventional
anti-MHC transgenic mice, the bone marrow and peripheral B cell compartments
of these knock-in mice were nearly normal, suggesting that editing was highly
efficient (58, 59).
IgVH genes can also be replaced by secondary V(D)J recombination through
the use of cryptic recombination signal sequences embedded in the VH gene (52,
60–62). Studies in mice and humans have shown evidence for VH replacement in
autoantibody-producing B cells (63–65). However, edited heavy chains frequently
show N nucleotide addition, suggesting that this process can occur in progenitor B
cells before light chain assembly (63, 66, 67). Such replacements would not be a
response to self-antigen binding. Nevertheless, it has been estimated that 5%–12%
of the human antibody repertoire is produced by VH replacement (68).
SITE OF EDITING
RAG expression was believed to be upregulated for a third time in immature B cells
that carry self-reactive receptors. In vitro experiments with both transgenic and
wild-type B cells showed increased RAG mRNA levels in cultures of developing
B cells following BCR cross-linking (69, 70). In addition bone marrow cells from
mice that carry anti-MHC (H-2Kk-b) antibody transgenes show higher levels of
RAG expression in the self-reactive background (71). Whether this increase in RAG
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expression is due to increased transcription or selection for cells that express high
levels of RAG remains to be determined. Immature B cells are not a homogeneous
population with respect to the level of RAG or BCR expression (Figure 1). Analysis
of the RAG2-GFP indicator mice showed that RAG levels were inversely correlated
with the density of the surface B cell receptor and B cell maturation (44, 72).
More mature B cells with higher levels of cell surface BCR expression showed
lower levels of RAG expression, suggesting that RAG expression is gradually
turned off as B cells mature (44, 72). Immature B cells that express high levels
of surface IgM are also more susceptible to negative selection (47, 48). Thus, the
apparent upregulation of RAG mRNA by BCR cross-linking in vitro could also be
a consequence of the selective survival of the cells that expressed higher levels of
RAGs and lower levels of BCR to begin with. Similarly, increased RAG expression
in transgenic B cells altered B cell maturation and enrichment for less mature
B cells that have lower levels of surface BCR and higher RAG expression.
To visualize the editing compartment in vivo, an Ig• allelic polymorphism was
created by targeted replacement of the mouse constant region gene (mC•) by
its human homologue (hC•) (73). In mice heterozygous for both a prerecombined
light chain (at the mC• locus) and the hC• allele, edited B cells were distinguished
as those cells that lost expression of the prerecombined mC• allele (73). Kinetic
studies showed that B lymphocytes undergoing editing were arrested for at least
two hours at the pre-BII cell stage when compared to unedited counterparts. The
delayed and edited B cell population showed higher levels of RAG expression than
unedited cells (73). Similar kinetic data have been obtained using mice that carry
a prerecombined V‚ gene instead of hC• (74). These observations are consistent
with a model where self-recognition activates secondary gene recombination by
inducing a developmental arrest at a stage where RAG1 and RAG2 are expressed.
In this model, cross-linking of the cell surface receptor by self-antigen does not
reinduce but sustains RAG1 and RAG2 expression and allows for secondary V(D)J
recombination. The model further clarifies how light chain allelic exclusion is
maintained in the presence of high levels of editing: B cells expressing innocuous
receptors transit rapidly from this stage to a compartment where RAG expression
and V(D)J recombination are turned off. Thus, B cells with a nonself-reactive
receptor are not exposed to prolonged V(D)J recombination, and the self-reactive
cells that are trapped in the editing compartment remain so only until they produce
a nonself-reactive receptor. In this regulated model for allelic exclusion, both
Ig• alleles could be accessible to the V(D)J recombinase simultaneously without
interfering with allelic exclusion.
EXTENT OF EDITING
Several lines of evidence suggest that secondary gene rearrangements are a com-
mon occurrence. For example, analysis of hybridomas generated from V•4J•4 and
V•8J•5 knock-in mice shows that both prerearranged light chains are replaced by
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editing in a large number of B lymphocytes (75). Likewise, the V•3-83J•2 light
chain is edited by secondary recombination occurring at the targeted allele and
this is accompanied by V(D)J recombination at the wild-type allele (58). Editing
has also been examined in Ig‚ expressing nontransgenic B cells in mice and man
(76, 77). Forty-seven percent of all mouse Ig‚ expressing B cells that have had
their Ig• genes inactivated by RS rearrangements show in-frame and potentially
functional Ig• genes (77). In man, almost all ‚ expressing B cells also carry a
rearranged • locus, whereas only 2% of • expressing B cells carry rearrangement
Ig ‚ genes (76). Furthermore, inactivated in-frame • joints are found in 30% of
human ‚ expressing cells (76). However, it was not determined why the in-frame
Ig• alleles were replaced in mouse or man.
A direct measurement of the extent of receptor editing was made using the hC•
and V‚ knock-in alleles (73, 74). These studies revealed that on average 25% of
the repertoire is the result of secondary gene replacements, indicating that editing
makes an important contribution to the normal antibody repertoire.
TRANSCRIPTION AND SECONDARY V(D)J
RECOMBINATION
Ig gene expression has been proposed to be essential for primary V(D)J recombina-
tion based on the direct correlation between the onset of germline transcription and
antibody gene recombination (78–80). In support of this model, targeted deletion
of transcription regulatory elements and some transcription factors impairs both
expression and recombination of TCR and Ig genes in vivo (81–85). In addition,
V(D)J recombination can only be induced in nonlymphoid cells when Ig genes are
transcribed (86). However, experiments with cell lines, transgenic recombination
substrates, and Pax5¡/¡ B cells show that transcription does not always correlate
with recombinational accessibility (87–91). Furthermore, the question of whether
there is a role of transcription per se as opposed to indirect enhancement of locus
accessibility has not been resolved.
The role of transcription in secondary recombination was investigated in mice
mutant for the transcriptional coactivator OcaB. OcaB (also known as Bob-1
and OBF-1) (92–94) forms a ternary complex with the transcription factor Oct-1
(or Oct-2) (95) on octamer motifs present in some Ig gene promoters. This octamer/
Oct-1(2)/OcaB ternary complex is thought to activate Ig gene transcription by spe-
cific interactions with the TATA-box-associated basal transcription machinery (96,
97). A direct correlation was found between light chain promoter transcription and
receptor editing (98). In the absence of OcaB, the Ig• chromatin domain is acces-
sible as measured by DNA demethylation, histone acetylation, promoter loading
of Oct-1, and low level transcription (98). However, open chromatin and low level
transcription were not sufficient for gene replacement by V(D)J recombination.
Only strongly transcribed promoters were replaced (98). Thus, a specific threshold
of V• gene transcription is required for secondary gene recombination.
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TERMINATION OF RAG EXPRESSION
RAG expression was initially thought to be confined to pro-B, pre-B, and immature
B cells in the bone marrow. However, several reports showed RAG mRNA and pro-
tein expression in germinal centers and in vitro activated B cells (99, 100). RAG1
and RAG2 mRNAs were detected in IgDCB cells cultured in the presence of CD40
(or lipopolysaccharide) and IL4, whereas splenic, Peyer’s patches, or lymph node
germinal center B cells showed abundant RAG1 protein expression as determined
by immunostaining (99, 100). Unlike most peripheral B cells, RAGC lymphocytes
(in both mice and humans) expressed several cell surface markers characteristic of
pro-B or pre-B cells such as ‚5, VpreB, TdT, GL7, low levels of B220, and IL7R
(99, 101–105). Ongoing recombination in these peripheral cells was implied by
the presence of DNA double-stranded break V(D)J intermediates (106–108) and
de novo formation of V‚1-J‚1 signal joints. However, the similarities between
bone marrow and peripheral RAGC B cells raised the possibility that these cells
might in fact represent B cell precursors. Experiments with transgenic and GFP
knock-in mice supported this hypothesis (44, 72). In both cases, GFP expression
in developing B and T cells mimics endogenous RAGs with the caveat that the
GFP expression level in the transgenic mice was one order of magnitude higher
than in the knock-in mice. Despite this, the results obtained with both models were
similar in that they showed that RAG-GFP expression in spleens was restricted to
immature new immigrant B cells (44, 72). Furthermore, adoptive transfer experi-
ments showed that mature B cells could not be induced to re-express RAGs during
an immune response in vivo or by culturing them in the presence of LPS and IL4
(44, 72). Interestingly, the RAGC immature B cell compartment in the spleen was
increased in animals immunized with antigen, infectious agents, or adjuvant only
at late stages of the immune response (44, 72, 109, 110). Increase in production
and export of immature B cells from the bone marrow (109, 110) accounted for
accumulation of these RAGC immigrants with kinetics similar to germinal center
formation (99, 100).
The levels of RAG expression in developing B cells decreased as they acquired
higher levels of surface IgM expression (see above). New immigrant B cells in the
periphery express substantially lower levels of RAG than immature B cells in the
bone marrow (44, 72). Nevertheless, alterations in the kinetics of immature B cell
migration to the periphery under conditions of immunization might explain reports
on RAG expression in peripheral B cells even in the absence of reinduction.
FROM EDITING TO DELETION
Termination of RAG expression prevents further V(D)J recombination and receptor
editing. To maintain tolerance, B cells that cannot edit self-reactive receptors must
be deleted or rendered anergic.
The idea that self-reactive clones are deleted during development was put for-
ward by Joshua Lederberg as a refinement of the clonal selection theory (5). This
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concept was confirmed by experiments in which mice were treated with anti-Igs
from birth and were found to be B cell depleted (111). The assumption linking
this result to tolerance was that anti-IgM antibodies must mimic autoantigens by
cross-linking the cell surface receptor. Likewise, bone marrow B cells challenged
in vitro with anti-IgM antibodies downregulate surface Ig and undergo apoptosis
(11, 13, 15, 19). In transgenic mice, expression of certain self-specificities also
induced clonal B cell deletion (8, 55, 112–114). In anti-MHC expressing B cells
exposure to antigen induced a developmental block that was concurrent with sec-
ondary VL gene recombination and replacement of cell surface receptors (48, 69,
70). Cells that failed to undergo successful editing were destined for death by
apoptosis. This idea was confirmed in experiments with RAG-deficient mice that
carried anti-DNA or self-MHC antibodies (115, 116). In the absence of secondary
recombination all autoreactive B cells were deleted and there were no peripheral
B cells (115, 116). Thus, antigen-induced apoptosis is a relatively late event in
bone marrow B cell development that is preceded by an editing permissive stage
that appears to be dependent on the bone marrow microenvironment (21, 48, 117).
CIS REGULATION OF RAG EXPRESSION
Highly regulated RAG expression is required for successful assembly of Ig and
TCR genes and normal lymphocyte development. On the other hand, silencing
RAGs in mature lymphoid cells is necessary in order to ensure genomic stability.
The RAG locus is peculiar in that RAG1 and RAG2 are adjacent but convergently
transcribed genes that entered the vertebrate genome at the time of emergence of
jawed fish (23–25, 118, 119). This unusual evolutionarily conserved genomic orga-
nization and the finding that RAG proteins can mediate transposition in vitro lead
to the hypothesis that these genes originate from a mobile element that entered the
vertebrate genome at the time of emergence of jawed fish (120, 121). Regulation of
RAG expression has been studied by transfection in cell lines in vitro and in vivo us-
ing bacterial artificial chromosome (BAC) transgenic mice, using green or yellow
fluorescent protein (GFP or YFP) as reporters in reconstitution experiments with
transfected ES cells, and by gene targeting. The disadvantage of the transfection
systems is that the transfected cells represent static stages in B or T cell develop-
ment and therefore the dynamic aspects of RAG regulation in developing lympho-
cytes cannot be explored. Nevertheless, much has been learned about the chromatin
structure and transcription factors that bind the murine and human RAG1 and RAG2
TATA-less promoters in vitro (122–126). The RAG1 promoter is not active or tissue
specific in transient transfections in the absence of a heterologous enhancer such
as the Ig E„ (125). In contrast, the murine RAG2 promoter is active in transient
transfection experiments in B and T cell lines, and the activity is dependent on
PAX5 and GATA3 (127, 128). However, stable transfectants showed little activity
for either RAG1 or RAG2 promoters in the absence of exogenous enhancers (129).
A second method used to evaluate RAG regulation was RAG2¡/¡ blastocyst
reconstitution by transfected RAG2 transgenes (130). These experiments suggested
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that all of the information required for RAG2 regulation was found in an 18 kb
genomic fragment extending from 9 kb upstream of the RAG2 promoter to 2.4 kb 30
of the untranslated region because it rescued thymocyte development (130). Similar
rescue of RAG2¡/¡ mice was also obtained with a yeast artificial chromosome
(RYAC) that contained both functional RAG genes and 12 kb of DNA 50 of RAG2
(131). The double positive (DP) compartment was fully reconstituted, and mature
CD4CCD8¡ and CD4¡CD8C thymocytes were present at one third of normal
levels in the RYAC/RAG2¡/¡ mice (131). However, this reconstitution of the DP
and single positive (SP) stage differed significantly from the normal wild-type T
cell development in that the mature cells were reduced by up to 70% and that the
TCRfi rearrangements were restricted to only the initial recombination at the 50 end
of the Jfi locus (131). Reconstitution was nonphysiological because RYAC failed
to induce detectable RAG1 or RAG2 transcription in DP T cells. Thus, neither the
18 kb genomic fragment (130) nor the RYAC contained sequences required for
RAG expression in DP T cells (131), and the RAG2¡/¡ blastocyst reconstitution is
not a sensitive assay to study RAG regulation in vivo.
Transgenic mouse and gene targeting experiments have confirmed the require-
ment for distal enhancers in regulating RAG expression in vivo. Two elements with
RAG promoter-enhancing activity have been identified: One element is active in
B cells and the second in DP T cells (32, 129, 131). Both of these elements are
on the RAG2 side of the locus, and both elements have effects on RAG1 and on
RAG2 promoters, suggesting a mechanism for achieving coordinate regulation of
the two genes by one set of genetic elements (32).
The B cell specific element is found in a 2.3 kb area located approximately
22 kb 50 of RAG2. In cell lines this element enhances transcription over back-
ground levels in a highly variegated manner (36% of the transfected cells show no
expression at all and only 10% of the clones show high levels of expression) (129).
Nevertheless, enhancement is found only in pro-B cells and is absent from T, adult
B, or nonlymphoid cell lines. Targeted deletion of this element from the mouse
genome leads to a B cell specific tenfold and a twofold decrease in RAG1 and
RAG2 mRNA levels, respectively, with no effect on RAG expression in DN or DP
cells (129). Although the targeted deletion shows that this element is required for
complete regulation, no ectopic or developmentally aberrant expression is reported
in its absence. It remains to be determined whether this element is sufficient to
drive tissue-specific and developmentally regulated expression of RAG, as is the
case for other enhancers such as the Ig„ enhancer.
The T cell specific element was identified in transgenic experiments with bac-
terial artificial chromosomes (BACs) that carry fluorescent protein indicator genes
in place of the RAG genes (32). These experiments showed that the transcription
of both RAG1 and RAG2 in DP thymocytes is coordinated by one or more cis
element(s) located between 32 and 87 kb 50 of RAG2. In addition to regulating ex-
pression in DP thymocytes, this region was also required to prevent position effect
variegation in developing T cells and B cells. Therefore, an element (or elements)
in this region is a required part of a traditional locus control region (132, 133).
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Like developing B cells, thymocytes express RAGs in two waves. V(D)J re-
combination is initiated with the first wave of RAG expression at the TCRfl locus
in CD4¡CD8¡ (DN) T cells. The TCRfl locus is analogous to the Ig heavy chain
locus, and DN T cells are analogous to pro-B cells (134). Once a TCRfl chain is
expressed, it combines with pre-Tfi and CD3 components to produce the pre-TCR
(135, 136). Similar to the pre-BCR, the pre-TCR downregulates RAG expression
and induces T cells to mature to the CD4CCD8C double positive (DP) stage. Upon
entering the DP stage there is a second wave of RAG expression and progressive
V(D)J recombination along the Jfi locus (29, 131, 137–139). V(D)J recombi-
nation is only turned off in DP cells when they express a TCR that recognizes
self-MHC with an affinity that allows for positive selection (140, 141). Thus, TCR
cross-linking in DP T cells is the signal that extinguishes RAG expression. This is
different from pre-B cells where receptor cross-linking delays extinction of RAG
expression and prolongs recombination leading to receptor editing (73).
We speculate that the separate B cell and DP T cell specific elements for RAG
regulation may provide a molecular explanation for why T cells turn off RAG
expression upon TCR cross-linking, whereas immature B cells prolong RAG ex-
pression and induce receptor editing upon BCR cross-linking.
The Annual Review of Immunology is online at http://immunol.annualreviews.org
LITERATURE CITED
1. Tonegawa S. 1983. Somatic generation of
antibody diversity. Nature 302:575–81
2. Silverstein AM. 2001. Autoimmunity ver-
sus horror autotoxicus: the struggle for
recognition. Nat. Immunol. 2:279–81
3. Burnet MF. 1959. The Clonal Selec-
tion Theory of Acquired Immunity. Cam-
bridge, UK: Cambridge Univ. Press
4. Talmage DW. 1959. Tumor development
in immunologically deficient nude mice
after exposure to chemical carcinogens.
Science 129:1643–48
5. Lederberg J. 1959. Genes and antibodies.
Science 129:1649–53
6. Gay D, Saunders T, Camper S, Weigert M.
1993. Receptor editing: an approach by
autoreactive B cells to escape tolerance.
J. Exp. Med. 177:999–1008
7. Tiegs SL, Russell DM, Nemazee D. 1993.
Receptor editing in self-reactive bone
marrow B cells. J. Exp. Med. 177:1009–
20
8. Nemazee DA, Burki K. 1989. Clonal dele-
tion of B lymphocytes in a transgenic
mouse bearing anti-MHC class I antibody
genes. Nature 337:562–66
9. Goodnow CC, Crosbie J, Adelstein S,
Lavoie TB, Smith-Gill SJ, et al. 1988.
Altered immunoglobulin expression and
functional silencing of self-reactive B
lymphocytes in transgenic mice. Nature
334:676–82
10. Landsteiner K. 1936. The Specificity of
Serological Reactions. New York: Dover
11. Sidman CL, Unanue ER. 1975. Receptor-
mediated inactivation of early B lympho-
cytes. Nature 257:149–51
12. Teale JM, Klinman NR. 1980. Tolerance
as an active process. Nature 288:385–87
13. Nossal GJ. 1983. Cellular mechanisms of
immunologic tolerance. Annu. Rev. Im-
munol. 1:33–62
14. Allman DM, Ferguson SE, Lentz VM,
Cancro MP. 1993. Peripheral B cell matu-
ration. II. Heat-stable antigen (hi) splenic
B cells are an immature developmental
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
11 Feb 2004 19:20 AR AR210-IY22-16.tex AR210-IY22-16.sgm LaTeX2e(2002/01/18) P1: IKH
REGULATION OF AUTOANTIBODIES 495
intermediate in the production of long-
lived marrow-derived B cells. J. Immunol.
151:4431–44
15. Norvell A, Mandik L, Monroe JG. 1995.
Engagement of the antigen-receptor on
immature murine B lymphocytes re-
sults in death by apoptosis. J. Immunol.
154:4404–13
16. Rolink AG, Andersson J, Melchers F.
1998. Characterization of immature B
cells by a novel monoclonal antibody, by
turnover and by mitogen reactivity. Eur. J.
Immunol. 28:3738–48
17. Forster I, Rajewsky K. 1990. The bulk
of the peripheral B-cell pool in mice is
stable and not rapidly renewed from the
bone marrow. Proc. Natl. Acad. Sci. USA
87:4781–84
18. Hao Z, Rajewsky K. 2001. Homeostasis
of peripheral B cells in the absence of B
cell influx from the bone marrow. J. Exp.
Med. 194:1151–64
19. Raff MC, Owen JJ, Cooper MD, Law-
ton ARd, Megson M, et al. 1975. Dif-
ferences in susceptibility of mature and
immature mouse B lymphocytes to anti-
immunoglobulin-induced immunoglobu-
lin suppression in vitro. Possible implica-
tions for B-cell tolerance to self. J. Exp.
Med. 142:1052–64
20. Gu H, Tarlinton D, Muller W, Rajewsky
K, Forster I. 1991. Most peripheral B cells
in mice are ligand selected. J. Exp. Med.
173:1357–71
21. Sandel PC, Monroe JG. 1999. Negative
selection of immature B cells by receptor
editing or deletion is determined by site of
antigen encounter. Immunity 10:289–99
22. Wardemann H, Yurasov S, Schaefer A,
Young JW, Meffre E, Nussenzweig MC.
2003. Predominant autoantibody produc-
tion by early human B cell precursors.
Science 301(5638):1374-77
23. Schatz DG, Oettinger MA, Baltimore D.
1989. The V(D)J recombination activat-
ing gene, RAG-1. Cell 59:1035–48
24. Oettinger MA, Schatz DG, Gorka C, Bal-
timore D. 1990. RAG-1 and RAG-2, ad-
jacent genes that synergistically activate
V(D)J recombination. Science 248:1517–
23
25. McBlane JF, van Gent DC, Ramsden DA,
Romeo C, Cuomo CA, et al. 1995. Cleav-
age at a V(D)J recombination signal re-
quires only RAG1 and RAG2 proteins and
occurs in two steps. Cell 83:387–95
26. Mombaerts P, Iacomini J, Johnson RS,
Herrup K, Tonegawa S, et al. 1992. RAG-
1-deficient mice have no mature B and T
lymphocytes. Cell 68:869–77
27. Shinkai Y, Rathbun G, Lam KP, Oltz EM,
Stewart V, et al. 1992. RAG-2-deficient
mice lack mature lymphocytes owing to
inability to initiate V(D)J rearrangement.
Cell 68:855–67
28. Schwarz K, Gauss GH, Ludwig L, Pan-
nicke U, Li Z, et al. 1996. RAG mutations
in human B cell-negative SCID. Science
274:97–99
29. Wilson A, Held W, MacDonald HR. 1994.
Two waves of recombinase gene expres-
sion in developing thymocytes. J. Exp.
Med. 179:1355–60
30. Grawunder U, Leu TM, Schatz DG,
Werner A, Rolink AG, et al. 1995. Down-
regulation of RAG1 and RAG2 gene ex-
pression in preB cells after functional
immunoglobulin heavy chain rearrange-
ment. Immunity 3:601–8
31. Allman D, Li J, Hardy RR. 1999. Commit-
ment to the B lymphoid lineage occurs be-
fore DH-JH recombination. J. Exp. Med.
189:735–40
32. Yu W, Misulovin Z, Suh H, Hardy RR,
Jankovic M, et al. 1999. Coordinate reg-
ulation of RAG1 and RAG2 by cell type-
specific DNA elements 50 of RAG2. Sci-
ence 285:1080–84
33. Igarashi H, Gregory SC, Yokota T, Sak-
aguchi N, Kincade PW. 2002. Transcrip-
tion from the RAG1 locus marks the
earliest lymphocyte progenitors in bone
marrow. Immunity 17:117–30
34. Alt FW, Yancopoulos GD, Blackwell TK,
Wood C, Thomas E, et al. 1984. Ordered
rearrangement of immunoglobulin heavy
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
11 Feb 2004 19:20 AR AR210-IY22-16.tex AR210-IY22-16.sgm LaTeX2e(2002/01/18) P1: IKH
496 JANKOVIC ET AL.
chain variable region segments. EMBO J.
3:1209–19
35. Li YS, Hayakawa K, Hardy RR. 1993.
The regulated expression of B lineage
associated genes during B cell differen-
tiation in bone marrow and fetal liver. J.
Exp. Med. 178:951–60
36. Ehlich A, Martin V, Muller W, Rajewsky
K. 1994. Analysis of the B-cell progenitor
compartment at the level of single cells.
Curr. Biol. 4:573–83
37. Nussenzweig MC, Shaw AC, Sinn E, Dan-
ner DB, Holmes KL, et al. 1987. Allelic
exclusion in transgenic mice that express
the membrane form of immunoglobulin
mu. Science 236:816–19
38. Manz J, Denis K, Witte O, Brinster R,
Storb U. 1988. Feedback inhibition of
immunoglobulin gene rearrangement by
membrane mu, but not by secreted mu
heavy chains [published erratum appears
in J. Exp. Med. 1989 June 1. 169(6):2269].
J. Exp. Med. 168:1363–81
39. Kitamura D, Rajewsky K. 1992. Targeted
disruption of mu chain membrane exon
causes loss of heavy-chain allelic exclu-
sion. Nature 356:154–56
40. Melchers F, Rolink A, Grawunder U, Win-
kler TH, Karasuyama H, et al. 1995. Pos-
itive and negative selection events during
B lymphopoiesis. Curr. Opin. Immunol.
7:214–27
41. Bassing CH, Swat W, Alt FW. 2002.
The mechanism and regulation of chro-
mosomal V(D)J recombination. Cell
109(Suppl.):S45–55
42. Chowdhury D, Sen R. 2001. Stepwise ac-
tivation of the immunoglobulin mu heavy
chain gene locus. EMBO J. 20:6394–403
43. Melchers F. 1995. The role of B cell
and pre-B cell receptors in development
and growth control of the B-lymphocyte
lineage. In Immunoglobulin Genes, ed.
T Honjo, FW Alt. pp. 33–56. London:
London Academic Ltd. 3rd ed.
44. Monroe RJ, Seidl KJ, Gaertner F, Han S,
Chen F, et al. 1999. RAG2:GFP knockin
mice reveal novel aspects of RAG2 ex-
pression in primary and peripheral lym-
phoid tissues. Immunity 11:201–12
45. Li Z, Dordai DI, Lee J, Desiderio S. 1996.
A conserved degradation signal regulates
RAG-2 accumulation during cell division
and links V(D)J recombination to the cell
cycle. Immunity 5:575–89
46. Ehlich A, Schaal S, Gu H, Kitamura D,
Muller W, et al. 1993. Immunoglobulin
heavy and light chain genes rearrange in-
dependently at early stages of B cell de-
velopment. Cell 72:695–704
47. Carsetti R, Kohler G, Lamers MC. 1995.
Transitional B cells are the target of neg-
ative selection in the B cell compartment.
J. Exp. Med. 181:2129–40
48. Melamed D, Benschop RJ, Cambier JC,
Nemazee D. 1998. Developmental regu-
lation of B lymphocyte immune tolerance
compartmentalizes clonal selection from
receptor selection. Cell 92:173–82
49. Radic MZ, Erikson J, Litwin S, Weigert
M. 1993. B lymphocytes may escape tol-
erance by revising their antigen receptors.
J. Exp. Med. 177:1165–73
50. Feddersen RM, Van Ness BG. 1985.
Double recombination of a single im-
munoglobulin kappa-chain allele: impli-
cations for the mechanism of rearrange-
ment. Proc. Natl. Acad. Sci. USA 82:
4793–97
51. Levy S, Campbell MJ, Levy R. 1989.
Functional immunoglobulin light chain
genes are replaced by ongoing rearrange-
ments of germline V kappa genes to down-
stream J kappa segment in a murine B cell
line. J. Exp. Med. 170:1–13
52. Kleinfield R, Hardy RR, Tarlinton D,
Dangl J, Herzenberg LA, et al. 1986. Re-
combination between an expressed im-
munoglobulin heavy-chain gene and a
germline variable gene segment in a Ly
1CB-cell lymphoma. Nature 322:843–46
53. Ritchie KA, Brinster RL, Storb U. 1984.
Allelic exclusion and control of endoge-
nous immunoglobulin gene rearrange-
ment in kappa transgenic mice. Nature
312:517–20
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
11 Feb 2004 19:20 AR AR210-IY22-16.tex AR210-IY22-16.sgm LaTeX2e(2002/01/18) P1: IKH
REGULATION OF AUTOANTIBODIES 497
54. Rusconi S, Kohler G. 1985. Transmission
and expression of a specific pair of re-
arranged immunoglobulin mu and kappa
genes in a transgenic mouse line. Nature
314:330–34
55. Erikson J, Radic MZ, Camper SA, Hardy
RR, Carmack C, et al. 1991. Expression of
anti-DNA immunoglobulin transgenes in
non-autoimmune mice. Nature 349:331–
34
56. Prak EL, Trounstine M, Huszar D,
Weigert M. 1994. Light chain editing
in kappa-deficient animals: a potential
mechanism of B cell tolerance. J. Exp.
Med. 180:1805–15
57. Li H, Jiang Y, Prak EL, Radic M, Weigert
M. 2001. Editors and editing of anti-DNA
receptors. Immunity 15:947–57
58. Pelanda R, Schwers S, Sonoda E, Torres
RM, Nemazee D, et al. 1997. Receptor
editing in a transgenic mouse model: site,
efficiency, and role in B cell tolerance and
antibody diversification. Immunity 7:765–
75
59. Chen C, Prak EL, Weigert M. 1997.
Editing disease-associated autoantibod-
ies. Immunity 6:97–105
60. Kleinfield RW, Weigert MG. 1989. Anal-
ysis of VH gene replacement events in a B
cell lymphoma. J. Immunol. 142:4475–82
61. Reth M, Gehrmann P, Petrac E, Wiese
P. 1986. A novel VH to VHDJH join-
ing mechanism in heavy-chain-negative
(null) pre-B cells results in heavy-chain
production. Nature 322:840–42
62. Wilson PC, Wilson K, Liu YJ, Banchereau
J, Pascual V, et al. 2000. Receptor revision
of immunoglobulin heavy chain variable
region genes in normal human B lympho-
cytes. J. Exp. Med. 191:1881–94
63. Chen C, Nagy Z, Prak EL, Weigert M.
1995. Immunoglobulin heavy chain gene
replacement: a mechanism of receptor
editing. Immunity 3:747–55
64. Pewzner-Jung Y, Friedmann D, Sonoda
E, Jung S, Rajewsky K, et al. 1998. B
cell deletion, anergy, and receptor edit-
ing in “knock in” mice targeted with
a germline-encoded or somatically mu-
tated anti-DNA heavy chain. J. Immunol.
161:4634–45
65. Itoh K, Meffre E, Albesiano E, Farber
A, Dines D, et al. 2000. Immunoglobulin
heavy chain variable region gene replace-
ment as a mechanism for receptor revi-
sion in rheumatoid arthritis synovial tissue
B lymphocytes. J. Exp. Med. 192:1151–
64
66. Sonoda E, Pewzner-Jung Y, Schwers S,
Taki S, Jung S, et al. 1997. B cell devel-
opment under the condition of allelic in-
clusion. Immunity 6:225–33
67. Cascalho M, Ma A, Lee S, Masat L, Wabl
M. 1996. A quasi-monoclonal mouse. Sci-
ence 272:1649–52
68. Zhang Z ZM, Wang YH, Munfus D, Huye
LE, Findley HW, et al. 2003. Contribution
of Vh gene replacement to the primary
B cell repertoire. Immunity 19:21–31
69. Hertz M, Nemazee D. 1997. BCR ligation
induces receptor editing in IgMCIgD-
bone marrow B cells in vitro. Immunity
6:429–36
70. Melamed D, Nemazee D. 1997. Self-
antigen does not accelerate immature
B cell apoptosis, but stimulates recep-
tor editing as a consequence of develop-
mental arrest. Proc. Natl. Acad. Sci. USA
94:9267–72
71. Nemazee D, Buerki K. 1989. Clonal dele-
tion of autoreactive B lymphocytes in
bone marrow chimeras. Proc. Natl. Acad.
Sci. USA 86:8039–43
72. Yu W, Nagaoka H, Jankovic M, Misulovin
Z, Suh H, et al. 1999. Continued RAG ex-
pression in late stages of B cell develop-
ment and no apparent re-induction after
immunization. Nature 400:682–87
73. Casellas R, Shih TA, Kleinewietfeld M,
Rakonjac J, Nemazee D, et al. 2001. Con-
tribution of receptor editing to the anti-
body repertoire. Science 291:1541–44
74. Oberdoerffer P, Novobrantseva TI, Rajew-
sky K. 2003. Expression of a targeted
lambda 1 light chain gene is develop-
mentally regulated and independent of
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
11 Feb 2004 19:20 AR AR210-IY22-16.tex AR210-IY22-16.sgm LaTeX2e(2002/01/18) P1: IKH
498 JANKOVIC ET AL.
Ig kappa rearrangements. J. Exp. Med.
197:1165–72
75. Prak EL, Weigert M. 1995. Light chain re-
placement: a new model for antibody gene
rearrangement. J. Exp. Med. 182:541–
48
76. Brauninger A, Goossens T, Rajewsky
K, Kuppers R. 2001. Regulation of im-
munoglobulin light chain gene rearrange-
ments during early B cell development
in the human. Eur. J. Immunol. 31:3631–
37
77. Retter MW, Nemazee D. 1998. Receptor
editing occurs frequently during normal B
cell development. J. Exp. Med. 188:1231–
38
78. Blackwell TK, Moore MW, Yancopoulos
GD, Suh H, Lutzker S, et al. 1986. Recom-
bination between immunoglobulin vari-
able region gene segments is enhanced by
transcription. Nature 324:585–89
79. Schlissel MS, Baltimore D. 1989. Acti-
vation of immunoglobulin kappa gene re-
arrangement correlates with induction of
germline kappa gene transcription. Cell
58:1001–7
80. Yancopoulos GD, Alt FW. 1985. Devel-
opmentally controlled and tissue-specific
expression of unrearranged VH gene seg-
ments. Cell 40:271–81
81. Chen J, Young F, Bottaro A, Stewart V,
Smith RK, et al. 1993. Mutations of the
intronic IgH enhancer and its flanking se-
quences differentially affect accessibility
of the JH locus. EMBO J. 12:4635–45
82. Serwe M, Sablitzky F. 1993. V(D)J re-
combination in B cells is impaired but
not blocked by targeted deletion of the
immunoglobulin heavy chain intron en-
hancer. EMBO J. 12:2321–27
83. Xu Y, Davidson L, Alt FW, Baltimore D.
1996. Deletion of the Ig kappa light chain
intronic enhancer/matrix attachment re-
gion impairs but does not abolish V kappa
J kappa rearrangement. Immunity 4:377–
85
84. Whitehurst CE, Schlissel MS, Chen J.
2000. Deletion of germline promoter PD
beta 1 from the TCR beta locus causes
hypermethylation that impairs D beta 1
recombination by multiple mechanisms.
Immunity 13:703–14
85. Corcoran AE, Riddell A, Krooshoop
D, Venkitaraman AR. 1998. Impaired
immunoglobulin gene rearrangement in
mice lacking the IL-7 receptor. Nature
391:904–7
86. Romanow WJ, Langerak AW, Goebel P,
Wolvers-Tettero IL, van Dongen JJ, et al.
2000. E2A and EBF act in synergy with
the V(D)J recombinase to generate a di-
verse immunoglobulin repertoire in non-
lymphoid cells. Mol. Cell 5:343–53
87. Alvarez JD, Anderson SJ, Loh DY. 1995.
V(D)J recombination and allelic exclu-
sion of a TCR beta-chain minilocus occurs
in the absence of a functional promoter. J.
Immunol. 155:1191–202
88. Okada A, Mendelsohn M, Alt F. 1994.
Differential activation of transcription
versus recombination of transgenic T cell
receptor beta variable region gene seg-
ments in B and T lineage cells. J. Exp.
Med. 180:261–72
89. Cherry SR, Baltimore D. 1999. Chromatin
remodeling directly activates V(D)J re-
combination. Proc. Natl. Acad. Sci. USA
96:10788–93
90. Angelin-Duclos C, Calame K. 1998. Ev-
idence that immunoglobulin VH-DJ re-
combination does not require germ line
transcription of the recombining variable
gene segment. Mol. Cell Biol. 18:6253–
64
91. Hesslein DG, Pflugh DL, Chowdhury D,
Bothwell AL, Sen R, et al. 2003. Pax5
is required for recombination of tran-
scribed, acetylated, 50 IgH V gene seg-
ments. Genes Dev. 17:37–42
92. Gstaiger M, Knoepfel L, Georgiev O,
Schaffner W, Hovens CM. 1995. A B-cell
coactivator of octamer-binding transcrip-
tion factors. Nature 373:360–62
93. Strubin M, Newell JW, Matthias P. 1995.
OBF-1, a novel B cell-specific coactivator
that stimulates immunoglobulin promoter
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
11 Feb 2004 19:20 AR AR210-IY22-16.tex AR210-IY22-16.sgm LaTeX2e(2002/01/18) P1: IKH
REGULATION OF AUTOANTIBODIES 499
activity through association with octamer-
binding proteins. Cell 80:497–506
94. Luo Y, Fujii H, Gerster T, Roeder RG.
1992. A novel B cell-derived coactivator
potentiates the activation of immunoglob-
ulin promoters by octamer-binding tran-
scription factors. Cell 71:231–41
95. Staudt LM, Lenardo MJ. 1991. Im-
munoglobulin gene transcription. Annu.
Rev. Immunol. 9:373–98
96. Luo Y, Roeder RG. 1995. Cloning, func-
tional characterization, and mechanism
of action of the B-cell-specific transcrip-
tional coactivator OCA-B. Mol. Cell Biol.
15:4115–24
97. Schubart DB, Rolink A, Kosco-Vilbois
MH, Botteri F, Matthias P. 1996. B-cell-
specific coactivator OBF-1/OCA-B/Bob1
required for immune response and germi-
nal centre formation. Nature 383:538–42
98. Casellas R, Jankovic M, Meyer G,
Gazumyan A, Luo Y, et al. 2002. OcaB
is required for normal transcription and
V(D)J recombination of a subset of im-
munoglobulin • genes. Cell 110:575–85
99. Han S, Zheng B, Schatz DG, Spanopoulou
E, Kelsoe G. 1996. Neoteny in lympho-
cytes: Rag1 and Rag2 expression in ger-
minal center B cells. Science 274:2094–
97
100. Hikida M, Mori M, Takai T, Tomochika
K, Hamatani K, et al. 1996. Reexpression
of RAG-1 and RAG-2 genes in activated
mature mouse B cells. Science 274:2092–
94
101. Giachino C, Padovan E, Lanzavecchia A.
1998. Re-expression of RAG-1 RAG-2
genes and evidence for secondary rear-
rangements in human germinal center B
lymphocytes. Eur. J. Immunol. 28:3506–
13
102. Girschick HJ, Grammer AC, Nanki T,
Mayo M, Lipsky PE. 2001. RAG1 and
RAG2 expression by B cell subsets from
human tonsil and peripheral blood. J. Im-
munol. 166:377–86
103. Hikida M, Ohmori H. 1998. Rearrange-
ment of lambda light chain genes in
mature B cells in vitro and in vivo.
Function of reexpressed recombination-
activating gene (RAG) products. J. Exp.
Med. 187:795–99
104. Meffre E, Papavasiliou F, Cohen P, de
Bouteiller O, Bell D, et al. 1998. Antigen
receptor engagement turns off the V(D)J
recombination machinery in human tonsil
B cells. J. Exp. Med. 188:765–72
105. Meffre E, Davis E, Schiff C, Cunningham-
Rundles C, Ivashkiv LB, et al. 2000. Cir-
culating human B cells that express sur-
rogate light chains edited receptors. Nat.
Immunol. 1:207–13
106. Hikida M, Nakayama Y, Yamashita Y,
Kumazawa Y, Nishikawa SI, et al. 1998.
Expression of recombination activating
genes in germinal center B cells: involve-
ment of interleukin 7 (IL-7) and the IL-7
receptor. J. Exp. Med. 188:365–72
107. Papavasiliou F, Casellas R, Suh H, Qin
XF, Besmer E, et al. 1997. V(D)J recom-
bination in mature B cells: a mechanism
for altering antibody responses. Science
278:298–301
108. Han S, Dillon SR, Zheng B, Shimoda M,
Schlissel MS, et al. 1997. V(D)J recombi-
nase activity in a subset of germinal center
B lymphocytes. Science 278:301–5
109. Gartner F, Alt FW, Monroe RJ, Seidl
KJ. 2000. Antigen-independent appear-
ance of recombination activating gene
(RAG)-positive bone marrow B cells in
the spleens of immunized mice. J. Exp.
Med. 192:1745–54
110. Nagaoka H, Gonzalez-Aseguinolaza G,
Tsuji M, Nussenzweig MC. 2000. Immu-
nization and infection change the number
of recombination activating gene (RAG)-
expressing B cells in the periphery by al-
tering immature lymphocyte production.
J. Exp. Med. 191:2113–20
111. Lawton AR 3rd, Asofsky R, Hylton MB,
Cooper MD. 1972. Suppression of im-
munoglobulin class synthesis in mice. I.
Effects of treatment with antibody to „-
chain. J. Exp. Med. 135:277–97
112. Chen C, Nagy Z, Radic MZ, Hardy RR,
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
11 Feb 2004 19:20 AR AR210-IY22-16.tex AR210-IY22-16.sgm LaTeX2e(2002/01/18) P1: IKH
500 JANKOVIC ET AL.
Huszar D, et al. 1995. The site and
stage of anti-DNA B-cell deletion. Nature
373:252–55
113. Hartley SB, Cooke MP, Fulcher DA,
Harris AW, Cory S, et al. 1993. Elimina-
tion of self-reactive B lymphocytes pro-
ceeds in two stages: arrested development
and cell death. Cell 72:325–35
114. Okamoto M, Murakami M, Shimizu A,
Ozaki S, Tsubata T, et al. 1992. A trans-
genic model of autoimmune hemolytic
anemia. J. Exp. Med. 175:71–79
115. Spanopoulou E, Roman CA, Corcoran
LM, Schlissel MS, Silver DP, et al.
1994. Functional immunoglobulin trans-
genes guide ordered B-cell differentia-
tion in Rag-1-deficient mice. Genes Dev.
8:1030–42
116. Xu H, Li H, Suri-Payer E, Hardy RR,
Weigert M. 1998. Regulation of anti-DNA
B cells in recombination-activating gene-
deficient mice. J. Exp. Med. 188:1247–54
117. Sandel PC, Gendelman M, Kelsoe G,
Monroe JG. 2001. Definition of a novel
cellular constituent of the bone marrow
that regulates the response of immature B
cells to B cell antigen receptor engage-
ment. J. Immunol. 166:5935–44
118. Fugmann SD, Lee AI, Shockett PE, Vil-
ley IJ, Schatz DG. 2000. The RAG pro-
teins and V(D)J recombination: com-
plexes, ends, and transposition. Annu. Rev.
Immunol. 18:495–527
119. Flajnik MF. 1998. Churchill and the im-
mune system of ectothermic vertebrates.
Immunol. Rev. 166:5–14
120. Hiom K, Melek M, Gellert M. 1998. DNA
transposition by the RAG1 and RAG2
proteins: a possible source of oncogenic
translocations. Cell 94:463–70
121. Agrawal A, Eastman QM, Schatz DG.
1998. Transposition mediated by RAG1
and RAG2 and its implications for the
evolution of the immune system. Nature
394:744–51
122. Zarrin AA, Fong I, Malkin L, Marsden
PA, Berinstein NL. 1997. Cloning and
characterization of the human recombina-
tion activating gene 1 (RAG1) and RAG2
promoter regions. J. Immunol. 159:4382–
94
123. Kurioka H, Kishi H, Isshiki H, Tagoh H,
Mori K, et al. 1996. Isolation and char-
acterization of a TATA-less promoter for
the human RAG-1 gene. Mol. Immunol.
33:1059–66
124. Kitagawa T, Mori K, Kishi H, Tagoh H,
Nagata T, et al. 1996. Chromatin structure
and transcriptional regulation of human
RAG-1 gene. Blood 88:3785–91
125. Fuller K, Storb U. 1997. Identification and
characterization of the murine Rag1 pro-
moter. Mol. Immunol. 34:939–54
126. Brown ST, Miranda GA, Galic Z, Hart-
man IZ, Lyon CJ, et al. 1997. Regulation
of the RAG-1 promoter by the NF-Y tran-
scription factor. J. Immunol. 158:5071–74
127. Lauring J, Schlissel MS. 1999. Distinct
factors regulate the murine RAG-2 pro-
moter in B- and T-cell lines. Mol. Cell.
Biol. 19:2601–12
128. Kishi H, Wei XC, Jin ZX, Fujishiro Y, Na-
gata T, et al. 2000. Lineage-specific reg-
ulation of the murine RAG-2 promoter:
GATA-3 in T cells and Pax-5 in B cells.
Blood 95:3845–52
129. Hsu LY, Lauring J, Liang HE, Greenbaum
S, Cado D, et al. 2003. A conserved tran-
scriptional enhancer regulates RAG gene
expression in developing B cells. Immu-
nity 19:105–17
130. Monroe RJ, Chen F, Ferrini R, Davidson
L, Alt FW. 1999. RAG2 is regulated dif-
ferentially in B and T cells by elements
50 of the promoter. Proc. Natl. Acad. Sci.
USA 96:12713–18
131. Yannoutsos N, Wilson P, Yu W, Chen
HT, Nussenzweig A, et al. 2001. The role
of recombination activating gene (RAG)
reinduction in thymocyte development
in vivo. J. Exp. Med. 194:471–80
132. Grosveld F, van Assendelft GB,
Greaves DR, Kollias G. 1987. Position-
independent, high-level expression of the
human beta-globin gene in transgenic
mice. Cell 51:975–85
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
11 Feb 2004 19:20 AR AR210-IY22-16.tex AR210-IY22-16.sgm LaTeX2e(2002/01/18) P1: IKH
REGULATION OF AUTOANTIBODIES 501
133. Li Q, Peterson KR, Fang X, Stamatoy-
annopoulos G. 2002. Locus control re-
gions. Blood 100:3077–86
134. Godfrey D, Kennedy J, Mombaerts P,
Tonegawa S, Zlotnik A. 1994. Onset of
TCR-beta gene rearrangement and role
of TCR-beta expression during CD3-
CD4-CD8-thymocyte differentiation. J.
Immunol. 152:4783–92
135. von Boehmer H, Fehling HJ. 1997. Struc-
ture and function of the pre-T cell re-
ceptor. Annu. Rev. Immunol. 15:433–
52
136. Kruisbeek AM, Haks MC, Carleton M,
Wiest DL, Michie AM, et al. 2000.
Branching out to gain control: how the
pre-TCR is linked to multiple functions.
Immunol. Today 21:637–44
137. Petrie H, Livak F, Schatz D, Strasser A,
Crispe I, et al. 1993. Multiple rearrange-
ments in T cell receptor alpha chain genes
maximize the production of useful thymo-
cytes. J. Exp. Med. 178:615–22
138. Shinkai Y, Koyasu S, Nakayama K, Mur-
phy KM, Loh DY, et al. 1993. Restoration
of T cell development in RAG-2-deficient
mice by functional TCR transgenes. Sci-
ence 259:822–25
139. Guo J, Hawwari A, Li H, Sun Z, Ma-
hanta SK, et al. 2002. Regulation of the
TCRalpha repertoire by the survival win-
dow of CD4(C)CD8(C) thymocytes. Nat.
Immunol. 3:469–76
140. Turka LA, Schatz DG, Oettinger MA,
Chun JJ, Gorka C, et al. 1991. Thymocyte
expression of RAG-1 and RAG-2: termi-
nation by T cell receptor cross-linking.
Science 16:778–81
141. Borgulya P, Kishi H, Uematsu Y, von
Boehmer H. 1992. Exclusion and inclu-
sion of fi and fl T cell receptor alleles.
Cell 69:529–37
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
REGULATION OF AUTOANTIBODIES C-1
Fi
gu
re
 1
B
 c
el
l d
ev
el
op
m
en
t. 
St
ag
es
, s
ta
tu
s o
f t
he
 im
m
un
og
lo
bu
lin
 h
ea
vy
 (I
gH
) a
nd
 lig
ht 
ch
ain
 (I
gL
) l
oc
i, e
xp
res
sio
n o
f t
he
 R
AG
 pr
o-
te
in
s (
the
 sh
ad
es 
of 
gre
en
 re
pre
sen
t th
e i
nte
ns
ity
 of
 ex
pre
ssi
on
 of
 th
e R
AG
2 p
rot
ein
 in
 m
ou
se 
RA
G2
-G
FP
in
di
ca
to
r s
tra
in
s).
 E
xp
res
sio
n o
f
th
e 
pr
e-
B 
an
d 
B 
ce
ll 
re
ce
pt
or
s, 
in
du
ct
io
n 
of
 re
ce
pt
or
 e
di
tin
g,
 a
nd
 a
po
pt
os
is 
by
 se
lf-
an
tig
en
s.
Jankovic.qxd  3/12/2004  2:05 PM  Page 1
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
P1: FRK
February 27, 2004 22:25 Annual Reviews AR210-FM
Annual Review of Immunology
Volume 22, 2004
CONTENTS
FRONTISPIECE—Leonard A. Herzenberg and Leonore A. Herzenberg x
GENETICS, FACS, IMMUNOLOGY, AND REDOX: A TALE OF TWO LIVES
INTERTWINED, Leonard A. Herzenberg and Leonore A. Herzenberg 1
SELF- AND NONSELF-RECOGNITION BY C-TYPE LECTINS ON
DENDRITIC CELLS, Teunis B.H. Geijtenbeek, Sandra J. van Vliet,
Anneke Engering, Bert A. ’t Hart, and Yvette van Kooyk 33
TRANSCRIPTIONAL CONTROL OF EARLY B CELL DEVELOPMENT,
Meinrad Busslinger 55
UBIQUITIN LIGASES AND THE IMMUNE RESPONSE, Yun-Cai Liu 81
LIGANDS FOR L-SELECTIN: HOMING, INFLAMMATION, AND BEYOND,
Steven D. Rosen 129
INTEGRINS AND T CELL–MEDIATED IMMUNITY, Jonathan T. Pribila,
Angie C. Quale, Kristen L. Mueller, and Yoji Shimizu 157
MULTIPLE ROLES OF ANTIMICROBIAL DEFENSINS, CATHELICIDINS,
AND EOSINOPHIL-DERIVED NEUROTOXIN IN HOST DEFENSE,
De Yang, Arya Biragyn, David M. Hoover, Jacek Lubkowski,
and Joost J. Oppenheim 181
STARTING AT THE BEGINNING: NEW PERSPECTIVES ON THE BIOLOGY
OF MUCOSAL T CELLS, Hilde Cheroutre 217
THE BCR-ABL STORY: BENCH TO BEDSIDE AND BACK,
Stephane Wong and Owen N. Witte 247
CD40/CD154 INTERACTIONS AT THE INTERFACE OF TOLERANCE
AND IMMUNITY, Sergio A. Quezada, Lamis Z. Jarvinen, Evan F. Lind,
and Randolph J. Noelle 307
THE THREE ES OF CANCER IMMUNOEDITING, Gavin P. Dunn,
Lloyd J. Old, and Robert D. Schreiber 329
AUTOIMMUNE AND INFLAMMATORY MECHANISMS IN
ATHEROSCLEROSIS, Georg Wick, Michael Knoflach, and Qingbo Xu 361
THE DYNAMIC LIFE OF NATURAL KILLER CELLS, Wayne M. Yokoyama,
Sungjin Kim, and Anthony R. French 405
v
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
P1: FRK
February 27, 2004 22:25 Annual Reviews AR210-FM
vi CONTENTS
THE ROLE OF COMPLEMENT IN THE DEVELOPMENT OF SYSTEMIC
LUPUS ERYTHEMATOSUS, Anthony P. Manderson, Marina Botto,
and Mark J. Walport 431
DROSOPHILA: THE GENETICS OF INNATE IMMUNE RECOGNITION AND
RESPONSE, Catherine A. Brennan and Kathryn V. Anderson 457
RAGS AND REGULATION OF AUTOANTIBODIES, Mila Jankovic,
Rafael Casellas, Nikos Yannoutsos, Hedda Wardemann,
and Michel C. Nussenzweig 485
THE ROLE OF SUPPRESSORS OF CYTOKINE SIGNALING (SOCS)
PROTEINS IN REGULATION OF THE IMMUNE RESPONSE,
Warren S. Alexander and Douglas J. Hilton 503
NATURALLY ARISING CD4+ REGULATORY T CELLS FOR
IMMUNOLOGIC SELF-TOLERANCE AND NEGATIVE CONTROL
OF IMMUNE RESPONSES, Shimon Sakaguchi 531
PHOSPHOINOSITIDE 3-KINASE: DIVERSE ROLES IN IMMUNE CELL
ACTIVATION, Jonathan A. Deane and David A. Fruman 563
IMMUNITY TO TUBERCULOSIS, Robert J. North and Yu-Jin Jung 599
MOLECULAR DEFECTS IN HUMAN SEVERE COMBINED
IMMUNODEFICIENCY AND APPROACHES TO IMMUNE
RECONSTITUTION, Rebecca H. Buckley 625
PHYSIOLOGICAL CONTROL OF IMMUNE RESPONSE AND
INFLAMMATORY TISSUE DAMAGE BY HYPOXIA-INDUCIBLE
FACTORS AND ADENOSINE A2A RECEPTORS, Michail V. Sitkovsky,
Dmitriy Lukashev, Sergey Apasov, Hidefumi Kojima, Masahiro Koshiba,
Charles Caldwell, Akio Ohta, and Manfred Thiel 657
T LYMPHOCYTE–ENDOTHELIAL CELL INTERACTIONS, Jaehyuk Choi,
David R. Enis, Kian Peng Koh, Stephen L. Shiao, and Jordan S. Pober 683
IMMUNOLOGICAL MEMORY TO VIRAL INFECTIONS,
Raymond M. Welsh, Liisa K. Selin, and Eva Szomolanyi-Tsuda 711
CENTRAL MEMORY AND EFFECTOR MEMORY T CELL SUBSETS:
FUNCTION, GENERATION, AND MAINTENANCE,
Federica Sallusto, Jens Geginat, and Antonio Lanzavecchia 745
CONTROL OF T CELL VIABILITY, Philippa Marrack and John Kappler 765
ASTHMA: MECHANISMS OF DISEASE PERSISTENCE AND PROGRESSION,
Lauren Cohn, Jack A. Elias, and Geoffrey L. Chupp 789
CD1: ANTIGEN PRESENTATION AND T CELL FUNCTION,
Manfred Brigl and Michael B. Brenner 817
CHEMOKINES IN INNATE AND ADAPTIVE HOST DEFENSE: BASIC
CHEMOKINESE GRAMMAR FOR IMMUNE CELLS, Antal Rot
and Ulrich H. von Andrian 891
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
P1: FRK
February 27, 2004 22:25 Annual Reviews AR210-FM
CONTENTS vii
INTERLEUKIN-10 AND RELATED CYTOKINES AND RECEPTORS,
Sidney Pestka, Christopher D. Krause, Devanand Sarkar, Mark R. Walter,
Yufang Shi, and Paul B. Fisher 929
INDEXES
Subject Index 981
Cumulative Index of Contributing Authors, Volumes 12–22 1011
Cumulative Index of Chapter Titles, Volumes 12–22 1018
ERRATA
An online log of corrections to Annual Review of Immunology chapters
may be found at http://immunol.annualreviews.org/errata.shtml
A
nn
u.
 R
ev
. I
m
m
un
ol
. 2
00
4.
22
:4
85
-5
01
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 C
A
LI
FO
RN
IA
 IN
ST
IT
U
TE
 O
F 
TE
CH
N
O
LO
G
Y
 o
n 
09
/0
8/
05
. F
or
 p
er
so
na
l u
se
 o
nl
y.
